Guided Therapeutics (GTHP) Total Non-Current Liabilities (2013 - 2025)
Guided Therapeutics recorded quarterly Total Non-Current Liabilities of $694000.0 in Q4 2025, up 778.48% quarter-over-quarter from $79000.0 in Q3 2025, and up 519.64% year-over-year from $112000.0 in Q4 2024.
Guided Therapeutics' Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $694000.0 for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 519.64% year-over-year to $694000.0; the TTM figure through Dec 2025 stood at $694000.0 (up 519.64% YoY), while the FY2025 annual figure was $694000.0, up 519.64% from the prior year.
- Total Non-Current Liabilities came in at $694000.0 for Q4 2025 at Guided Therapeutics, up from $79000.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.8 million in Q4 2021 to a low of $35000.0 in Q2 2025.
- A 5-year average of $870950.0 and a median of $710500.0 in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities tumbled 90.6% in 2024 and jumped 519.64% in 2025, its largest moves.
- Guided Therapeutics' Total Non-Current Liabilities stood at $1.8 million in 2021, then decreased by 22.95% to $1.4 million in 2022, then slumped by 51.74% to $666000.0 in 2023, then plunged by 83.18% to $112000.0 in 2024, then surged by 519.64% to $694000.0 in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $694000.0, $79000.0, and $35000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 694,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 694,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 96,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 186,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Dec 31, 2023 | 666,000.00 |
| Sep 30, 2023 | 693,000.00 |
| Jun 30, 2023 | 727,000.00 |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.27 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 1.72 Mn |
| Mar 31, 2021 | 1.07 Mn |
| Dec 31, 2020 | 3.24 Mn |
| Sep 30, 2020 | 6.82 Mn |
| Jun 30, 2020 | 8.74 Mn |
| Mar 31, 2020 | 2.49 Mn |
| Dec 31, 2019 | 5.71 Mn |
| Sep 30, 2019 | 6.73 Mn |
| Jun 30, 2019 | 7.10 Mn |
| Mar 31, 2019 | 4.72 Mn |
| Dec 31, 2018 | 5.07 Mn |
| Sep 30, 2018 | 4.00 Mn |
| Jun 30, 2018 | 12.56 Mn |
| Mar 31, 2018 | 12.19 Mn |
| Dec 31, 2017 | 7.96 Mn |
| Sep 30, 2017 | 11.42 Mn |
| Jun 30, 2017 | 10.78 Mn |
| Mar 31, 2017 | 9.70 Mn |
| Dec 31, 2016 | 9.34 Mn |
| Sep 30, 2016 | 8.55 Mn |
| Jun 30, 2016 | 7.96 Mn |
| Mar 31, 2016 | 1.79 Mn |
| Dec 31, 2015 | 2.61 Mn |
| Sep 30, 2015 | 1.29 Mn |
| Jun 30, 2015 | 1.98 Mn |
| Mar 31, 2015 | 2.41 Mn |
| Dec 31, 2014 | 2.89 Mn |
| Sep 30, 2014 | 3.55 Mn |
| Jun 30, 2014 | 3.80 Mn |
| Mar 31, 2014 | 1.11 Mn |
| Dec 31, 2013 | 1.65 Mn |
| Sep 30, 2013 | 798,000.00 |
| Jun 30, 2013 | 1.03 Mn |